Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Onconova Therapeutic (ONTX)

Onconova Therapeutic (ONTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Onconova Therapeutics Announces Participation at the Upcoming H.C. Wainwright 23rd Annual Global Investment Conference

Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company will...

ONTX : 4.87 (+0.62%)
Onconova Therapeutics, Inc. (ONTX) Reports Q2 Loss, Tops Revenue Estimates

Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue surprises of 3.57% and 35.71%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?...

ONTX : 4.87 (+0.62%)
Onconova Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

Onconova Therapeutics, Inc. (NASDAQ: ONTX) ("Onconova"), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced financial...

ONTX : 4.87 (+0.62%)
Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2021 Financial Results on August 12, 2021

Onconova Therapeutics, Inc. (NASDAQ: ONTX) ("Onconova"), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the...

ONTX : 4.87 (+0.62%)
Will Onconova Therapeutics, Inc. (ONTX) Report Negative Q2 Earnings? What You Should Know

Onconova Therapeutics, Inc. (ONTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ONTX : 4.87 (+0.62%)
Global Brain Tumor Diagnosis & Treatment Market Could Exceed $880 Million By 2027

PALM BEACH,  Fla., /PRNewswire/ -- Cancer is a foremost public health problem globally and is the second leading cause of death in the United States.  According to the National Brain Tumor Society,...

CNSP : 1.5300 (-1.29%)
MNKD : 4.56 (-2.36%)
ITRM : 0.6030 (-0.12%)
ONTX : 4.87 (+0.62%)
PFE : 44.47 (-0.67%)
Onconova Therapeutics Provides an Update on the Phase 1/2a Trial of Rigosertib-Nivolumab Combination in KRAS+ Non-Small Cell Lung Cancer

Expansion of trial underway at highest dose in the current protocol, and continued dose escalation under consideration

ONTX : 4.87 (+0.62%)
Onconova Therapeutics Regains Compliance with Nasdaq Continued Listing Requirement

Onconova Therapeutics, Inc. (NASDAQ: ONTX) ("Onconova"), a biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced that on June 17, 2021 it received...

ONTX : 4.87 (+0.62%)
Onconova Therapeutics Announces the Peer-Reviewed Publication of Preclinical Data Demonstrating the Synergistic Anti-Cancer Activity of Rigosertib Combined with Immune Checkpoint Blockade

Rigosertib synergistically combined with immune checkpoint blockade (ICB) to improve tumor growth inhibition and survival in a murine melanoma model that did not respond to ICB alone

ONTX : 4.87 (+0.62%)
Thinking about buying stock in Irving Resources, Soligenix, Exela Technologies, Soleno Therapeutics, or Onconova Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IRV, SNGX, XELA, SLNO, and ONTX.

IRVRF : 0.9198 (+5.12%)
IRV.CN : 1.160 (+0.87%)
ONTX : 4.87 (+0.62%)
SLNO : 0.9210 (+1.68%)
SNGX : 1.0600 (-3.64%)
XELA : 2.10 (+1.94%)

Barchart Exclusives

US Dollar Index Bulls Toot Their Own Horns
The short-term rally by the US dollar index may not make a lot of sense, but at least it's consistent. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar